Aleksandra Kukla, Yogish C Kudva, Pavel Navratil, Sukhdeep S Sahi, Roberto P Benzo, David C Fipps, Avery E Erickson, Rachael R Majorowicz, Matthew M Clark, Carrie A Schinstock, Pankaj Shah, Meera Shah, Tayyab S Diwan
Bariatric surgery is increasingly recognized as a safe and effective treatment for obesity in patients with chronic kidney disease (CKD), including stages 4, 5, and 5D (on dialysis). Among the available surgical methods, sleeve gastrectomy (SG) is the most commonly performed weight loss procedure and is mainly done to facilitate kidney transplantation (KT). However, many KT candidates treated with SG remain on the transplant waiting list for months to years, with some never receiving a transplant. Therefore, appropriate candidates for SG must be selected, and post-SG management should address the unique needs of this population, with a focus on sustaining the metabolic benefits of surgery while minimizing potential side effects related to rapid weight loss which may inadvertently lead to muscle and bone catabolism...
March 2024: Mayo Clinic Proceedings